The Impact of Histological Variant on Oncological Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.


Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 23 05 2020
revised: 08 06 2020
accepted: 18 06 2020
entrez: 31 7 2020
pubmed: 31 7 2020
medline: 11 8 2020
Statut: ppublish

Résumé

Bladder cancer with histological variant (HV) has different morphological features from usual urothelial carcinoma (UC). The aim of this study was to evaluate the oncological outcomes of HV in patients with bladder cancer. We retrospectively evaluated data from 102 patients with UC of the bladder treated with radical cystectomy between 1998 and 2017. Pathological findings including HV were assigned by one dedicated pathologist. Recurrence-free survival (RFS) and cancer-specific survival (CSS) and overall survival (OS) were estimated by Cox regression models. In total, 26 patients (25.5%) had HV, and the most common variant was squamous differentiation, followed by glandular differentiation and a mixed variant consisted of squamous and glandular differentiation. The presence of HV was associated with RFS and CSS (p=0.018, p=0.036, respectively). HV has more aggressive tumor biological features compared to those with pure UC. The presence of HV was associated with poor survival.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
Bladder cancer with histological variant (HV) has different morphological features from usual urothelial carcinoma (UC). The aim of this study was to evaluate the oncological outcomes of HV in patients with bladder cancer.
PATIENTS AND METHODS METHODS
We retrospectively evaluated data from 102 patients with UC of the bladder treated with radical cystectomy between 1998 and 2017. Pathological findings including HV were assigned by one dedicated pathologist. Recurrence-free survival (RFS) and cancer-specific survival (CSS) and overall survival (OS) were estimated by Cox regression models.
RESULTS RESULTS
In total, 26 patients (25.5%) had HV, and the most common variant was squamous differentiation, followed by glandular differentiation and a mixed variant consisted of squamous and glandular differentiation. The presence of HV was associated with RFS and CSS (p=0.018, p=0.036, respectively).
CONCLUSION CONCLUSIONS
HV has more aggressive tumor biological features compared to those with pure UC. The presence of HV was associated with poor survival.

Identifiants

pubmed: 32727806
pii: 40/8/4787
doi: 10.21873/anticanres.14481
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4787-4793

Informations de copyright

Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Kenshiro Takemoto (K)

Department of Urology, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan kenshiro_takemoto@yahoo.co.jp.
Department of Urology, Hiroshima Prefectural Hospital, Hiroshima, Japan.
Department of Urology, Nakatsu Daiichi Hospital, Oita, Japan.

Jun Teishima (J)

Department of Urology, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.

Yuki Kohada (Y)

Department of Urology, Hiroshima Prefectural Hospital, Hiroshima, Japan.

Kenichiro Ikeda (K)

Department of Urology, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.

Hirotaka Nagamatsu (H)

Department of Urology, Nakatsu Daiichi Hospital, Oita, Japan.

Akihiro Goriki (A)

Department of Urology, Hiroshima Prefectural Hospital, Hiroshima, Japan.

Shogo Inoue (S)

Department of Urology, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.

Tetsutaro Hayashi (T)

Department of Urology, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.

Mitsuru Kajiwara (M)

Department of Urology, Hiroshima Prefectural Hospital, Hiroshima, Japan.

Akio Matsubara (A)

Department of Urology, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH